Generation Bio Profit Margin

The latest profit margin for GBIO is -410.13% as of September 2025. That compares with -782.87% in the prior-year period — up 47.6% year over year. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside Generation Bio's historical trend and sector peers before judging valuation or financial health.

Over the past year, GBIO's profit margin moved from -782.87% to -410.13% — a 47.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Generation Bio's valuation or profitability profile.

Against Healthcare companies, GBIO currently prints -410.13% for profit margin, while the sector average sits near 13.89%. That is roughly 3052.7% below the sector mean. Large gaps often invite a closer look at Generation Bio's growth, margins, and balance sheet.

Profit Margin shows how effectively Generation Bio converts resources into returns. At -410.13%, GBIO may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -782.87% in the prior-year period — up 47.6% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting GBIO's profit margin (-410.13%), review year-over-year change from -782.87%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.